Omalizumab-associated eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). (Record no. 26790852)

MARC details
000 -LEADER
fixed length control field 01374 a2200349 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517133849.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201712s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1534-4436
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.anai.2016.12.003
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Nazir, Salik
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20171212
245 00 - TITLE STATEMENT
Title Omalizumab-associated eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Date of publication, distribution, etc. Mar 2017
300 ## - PHYSICAL DESCRIPTION
Extent 372-374.e1 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Asthmatic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Churg-Strauss Syndrome
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Omalizumab
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tachamo, Niranjan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fareedy, Shoaib Bilal
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Khan, Muhammad Sohail
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lohani, Saroj
773 0# - HOST ITEM ENTRY
Title Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Related parts vol. 118
-- no. 3
-- p. 372-374.e1
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.anai.2016.12.003">https://doi.org/10.1016/j.anai.2016.12.003</a>
Public note Available from publisher's website

No items available.